Clinical trials start for stroke drug developed by Scripps Research, USC, and ZZ Biotech
Clinical trials start this week for a stroke drug initially created by a team led by scientists at The Scripps Research Institute and the University of Southern California (USC), and further developed by biotech company ZZ ...
Medications
Aug 08, 2012 |
not rated yet |
0
Experimental drug may extend therapeutic window for stroke
A team led by a physician-scientist at the University of Southern California (USC) has created an experimental drug that reduces brain damage and improves motor skills among stroke-afflicted rodents when given with federally ...
Cardiology
Jul 17, 2012 |
not rated yet |
0
GMO in sport: Genetically Modified Olympians?
As athletes get ready to smash Olympic records in London, scientists are in a high-stakes race of their own to develop a test that will unmask anyone altering their genes in a desperate quest for gold.
Other
Jul 15, 2012 |
3 / 5 (1) |
0
'Master switch' experimental drug could treat different cancers
(Medical Xpress) -- A unique multi-target experimental drug could treat a range of cancer types, according to research published in Clinical Cancer Research today. ...
Cancer
Jul 11, 2012 |
5 / 5 (1) |
0
|
Investigational diabetes drug may have fewer side effects
Drugs for type 2 diabetes can contribute to weight gain, bone fractures and cardiovascular problems, but in mice, an investigational drug appears to improve insulin sensitivity without those troublesome side ...
Medical research
Jun 04, 2012 |
5 / 5 (1) |
0
|
Research shows promising treatments against skin cancer
Two new experimental treatments against advanced melanoma have shown promise in keeping the deadly skin cancer at bay, according to research presented in the United States on Monday.
Cancer
Jun 04, 2012 |
not rated yet |
0
New breast cancer drug halts tumor growth better than standard therapy
A new cancer treatment that links chemotherapy with an agent that homes in on specific breast cancer cells was significantly better than the current drug regimen at keeping patients' advanced tumors from progressing, according ...
Cancer
Jun 03, 2012 |
not rated yet |
0
Clinical trial design supports original accelerated approval of sunitinib for GIST
Patients benefitted from an important design element in the pivotal phase III clinical trial that led to Food and Drug Administration and worldwide regulatory approval of sunitinib for the treatment of gastrointestinal stromal ...
Cancer
Jun 01, 2012 |
not rated yet |
0
Study reveals how the world's first drug for amyloid disease works
Scientists from The Scripps Research Institute and Pfizer Inc. have published a new study showing how a new drug called tafamidis (Vyndaqel) works. Tafamidis, approved for use in Europe and currently under ...
Medical research
May 29, 2012 |
5 / 5 (3) |
0
|
Diabetes drug could be a promising therapy for traumatic brain injury
Although the death toll is relatively low for people who suffer from traumatic brain injury (TBI), it can have severe, life-long consequences for brain function. TBI can impair a patient's mental abilities, impact memory ...
Neuroscience
May 29, 2012 |
5 / 5 (1) |
0
|
Dabrafenib shrinks melanoma brain metastases in phase I clinical trial
An experimental drug targeting a common mutation in melanoma successfully shrank tumors that spread to the brain in nine out of 10 patients in part of an international phase I clinical trial report in the May 18 issue of ...
Cancer
May 17, 2012 |
not rated yet |
0
|
Experimental agent may help older people with chronic leukemia
The experimental drug ibrutinib (PCI-32765) shows great promise for the treatment of elderly patients with chronic lymphocytic leukemia (CLL), according to interim findings from a clinical trial.
Cancer
May 16, 2012 |
5 / 5 (1) |
0
Trial set to see if drug can prevent Alzheimer's
(HealthDay) -- Researchers are preparing to test an experimental drug in people genetically primed to develop Alzheimer's disease.
Alzheimer's disease & dementia
May 16, 2012 |
5 / 5 (1) |
0
|
Scientists hunt ways to stall Alzheimer's earlier
(AP) -- Look for a fundamental shift in how scientists hunt ways to ward off the devastation of Alzheimer's disease - by testing possible therapies in people who don't yet show many symptoms, before too much ...
Alzheimer's disease & dementia
May 16, 2012 |
not rated yet |
0
FDA issues warning on controversial MS treatment
(HealthDay) -- Doctors and patients need to be aware of the potential risk of injuries and death associated with an experimental treatment for multiple sclerosis called liberation therapy, the U.S. Food and ...
Diseases, Conditions, Syndromes
May 10, 2012 |
not rated yet |
1
